Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphopenia 1Esophageal Neoplasms 1

Interventions

Specimen Handling 321Magnetic Resonance Spectroscopy 276pembrolizumab 265Carboplatin 190Cyclophosphamide 184Biopsy 179Cisplatin 163Paclitaxel 137Gemcitabine 137Bevacizumab 124fludarabine 119Nivolumab 117Radiotherapy 114Oxaliplatin 92Docetaxel 90venetoclax 89Fluorouracil 88Capecitabine 88Dexamethasone 86Pemetrexed 75Drug Therapy 73Rituximab 72Leucovorin 71durvalumab 70Blood Specimen Collection 69Radiosurgery 68atezolizumab 67Standard of Care 67Doxorubicin 65Radiation 63

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × SARS-CoV-2 inactivated vaccines × 90 days × Clear all
NCT06181656 2026-05-20

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

M.D. Anderson Cancer Center

Recruiting
80 enrolled
Gastrointestinal

Esophageal Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡